These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9258087)

  • 1. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
    Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
    J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
    Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
    J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
    Loughman NT; Lin BP; Dent OF; Newland RC
    Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
    Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
    J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time.
    Borgström E; Gustafson H
    Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy.
    Katz RL; Sinkre PA; Zhang HH; Kidd L; Johnston D
    Cancer; 1997 Dec; 81(6):354-64. PubMed ID: 9438461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
    Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
    Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of flow cytometry in superficial bladder cancer.
    Di Silverio F; von Heland M; De Berardinis E; Izzi R; Buscarini M; De Vita R; Forte R; Seccareccia F; Menotti A
    Eur Urol; 1992; 21 Suppl 1():22-5. PubMed ID: 1425833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
    Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
    Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.